Figure 3
Figure 3. CMV reactivation induces an increase of NKG2C+ NK cells and a more mature NK-cell phenotype in the first year after transplantation. NKG2C expression (left panel), mean fluorescence intensity (MFI, right panel, A), CD56dim expression (B, left top panel), NKG2A expression (B, right top panel), and KIR expression based on a cocktail of Abs against CD158a/h, CD158b/j, and CD158e (B, left bottom panel) and CD57 expression (B, right bottom panel) were measured on CD56+ CD3− NK cells from seronegative (○, n = 10), seropositive (no CMV reactivation; ■, n = 5) and seropositive (CMV reactivation; ▵, n = 8) recipients at day 28, day 60, day 100, 6 months, and 1 year after transplantation. Points represent the means ± SEM. The slope of time was compared between recipients who reactivated CMV and combined recipients who did not reactivate CMV using a linear mixed model.

CMV reactivation induces an increase of NKG2C+ NK cells and a more mature NK-cell phenotype in the first year after transplantation. NKG2C expression (left panel), mean fluorescence intensity (MFI, right panel, A), CD56dim expression (B, left top panel), NKG2A expression (B, right top panel), and KIR expression based on a cocktail of Abs against CD158a/h, CD158b/j, and CD158e (B, left bottom panel) and CD57 expression (B, right bottom panel) were measured on CD56+ CD3 NK cells from seronegative (○, n = 10), seropositive (no CMV reactivation; ■, n = 5) and seropositive (CMV reactivation; ▵, n = 8) recipients at day 28, day 60, day 100, 6 months, and 1 year after transplantation. Points represent the means ± SEM. The slope of time was compared between recipients who reactivated CMV and combined recipients who did not reactivate CMV using a linear mixed model.

Close Modal

or Create an Account

Close Modal
Close Modal